Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- IONQ.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
IONQ (IONQ) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
PARTIAL SELL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
SELL ALL$32
-18.5%5-Year
PARTIAL SELL$35
-11.4%Published batch insight
Acquired Foundry Expansion Conceals Severe Margin Erosion Amid Restrictive Monetary Regimes
Independent analysis reveals high consensus that aggressive foundry acquisitions mask structural gross margin dilution and persistent operating cash burn. While trapped atomic ion fidelity and sovereign defense procurement establish strategic moats, severe duration sensitivity under elevated benchmark yields ensures multiyear multiple compression outweighs nominal consolidated revenue growth.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Superintelligence (Anthropologist), Michael Burry (Vulture), Universal Investor (Polymath), Warren Buffett (Value Purist), J.P. Morgan (Titan), Sherlock Holmes (Whistleblower), Machiavelli (Insider), Elon Musk (Visionary), Ray Dalio (Strategist). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTFull published thesis
Executive Summary
If you invested $10,000 in IONQ at the forecast anchor (2026-09-18): $8,860 in five years versus $13,892 for S&P 500 benchmark.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 35.64 | -8.91% | -8.91% | Post-merger integration expenses and initial foundry margin dilution confront persistent monetary tightening. Elevated Treasury yields near five percent spark multiple compression across speculative technology, driving equity de-rating despite resilient headline sovereign bookings. |
| Q1 2027 | 33.45 | -6.15% | -14.51% | Full-year reporting exposes consolidated gross margins compressing below thirty percent due to acquired foundry operations. Institutional investors re-anchor valuation models toward industrial hardware benchmarks, prompting multiple de-rating as annual operating cash burn nears five hundred million. |
| Q2 2027 | 32.78 | -2.02% | -16.24% | Unveiling commercial progress on the 256-qubit Superion platform and defense research milestones prompts a tactical relief rally. Speculative short covering temporarily offsets broader investor concerns regarding ongoing cleanroom capital intensity and macroeconomic discount rates. |
| Q3 2027 | 31.88 | -2.73% | -18.53% | Customer acceptance testing and qualification cycles for new hardware extend longer than anticipated, slowing cash conversion. Persistently high interest rates and ongoing share dilution dampen enthusiasm, pushing the stock into intermediate multiple consolidation. |
| Q4 2027 | 31.24 | -2.01% | -20.16% | Year-end federal defense appropriations and sovereign quantum networking awards deliver non-dilutive backlog expansion. High-margin government hardware delivery milestones provide vital top-line visibility, generating an operational price floor and lifting shares into calendar year-end. |
| Q1 2028 | 31.44 | +0.63% | -19.66% | Annual financial disclosures confirm consolidated revenue scaling past six hundred million dollars, driven by system shipments. However, persistent foundry maintenance expenses and research payrolls keep free cash flow negative, capping intermediate multiple expansion. |
| Q2 2028 | 31.30 | -0.44% | -20.01% | Successful bench testing of integrated photonic interconnects demonstrates modular multi-core scaling, reducing perceived technical execution risk. Expanded cloud compute utilization across hyperscaler platforms improves contribution margins, driving constructive institutional accumulation across the quarter. |
| Q3 2028 | 30.35 | -3.04% | -22.45% | Competing architectural announcements from superconducting and neutral-atom consortia generate narrative friction. Equity markets trim exposure as management signals elevated capital expenditures for fabrication facility modernizations, inducing moderate quarterly valuation pullbacks. |
| Q4 2028 | 31.15 | +2.66% | -20.38% | Commercial biopharma and materials optimization pilots convert into multi-year hybrid compute subscriptions. Narrowing quarterly operating cash deficits and robust sovereign cybersecurity renewals restore investor confidence, triggering a solid speculative rally into year-end. |
| Q1 2029 | 30.84 | -1.00% | -21.18% | Fiscal disclosures show total revenue approaching eight hundred million dollars, yet share count expansion moderates per-share economic gains. Investors reprice top-line growth against ongoing dilution, maintaining a sober valuation multiple aligned with specialized technology peers. |
| Q2 2029 | 31.65 | +2.62% | -19.11% | Demonstration of early fault-tolerant logical qubit error suppression on commercial workloads sparks renewed institutional engagement. Evidence that modular trapped-ion traps surpass classical heuristic limits on specialized tasks drives steady equity appreciation on high volume. |
| Q3 2029 | 31.00 | -2.06% | -20.78% | Broader macroeconomic cooling and cyclical semiconductor softness prompt routine multiple digestion across deep tech. Investors pause to evaluate enterprise pilot renewal rates while ongoing foundry depreciation expenses keep reported GAAP net income subdued. |
| Q4 2029 | 31.85 | +2.76% | -18.59% | High-margin cloud algorithmic compute revenue begins outpacing legacy contract manufacturing within the corporate sales mix. Improving blended gross margins validate the vertical integration thesis, driving solid share price appreciation as enterprise backlogs expand. |
| Q1 2030 | 31.82 | -0.12% | -18.69% | Full-year results confirm consolidated revenue crossing one billion dollars as operational cash burn visibly contracts. While capital intensity remains significant, improving unit economics across system deployments support steady institutional valuation multiples into early spring. |
| Q2 2030 | 33.09 | +4.00% | -15.44% | Volume delivery of interconnected modular quantum processing units to sovereign defense and national laboratories cements strategic infrastructure status. Expanding software licensing royalties improve earnings quality, generating constructive quarterly gains despite baseline competitive pressures. |
| Q3 2030 | 32.68 | -1.23% | -16.48% | Periodic silicon cleanroom maintenance cycles and broader technology sector profit-taking induce tactical consolidation. The market absorbs minor per-share dilution from employee equity vesting while awaiting formal third-quarter enterprise software deployment metrics. |
| Q4 2030 | 33.25 | +1.75% | -15.02% | Federal post-quantum cryptographic security deadlines generate an urgent surge in government and financial infrastructure upgrade orders. Accelerating hardware verification contracts and high-margin networking sales drive strong quarterly share performance into year-end. |
| Q1 2031 | 33.46 | +0.63% | -14.48% | Financial reports demonstrate full-year operating cash flow approaching positive breakeven, substantially eliminating existential financing concerns. Decreased reliance on secondary equity offerings bolsters investor sentiment, allowing fundamental institutional quality-growth accumulation to expand. |
| Q2 2031 | 34.45 | +2.95% | -11.96% | Widespread enterprise adoption of hybrid classical-quantum cloud architectures cements trapped-ion hardware as essential high-performance computing accelerators. Expanding commercial software margins fuel consistent quarterly price appreciation as market consensus endorses platform viability. |
| Q3 2031 | 34.67 | +0.64% | -11.40% | The five-year forecast horizon concludes with revenue surpassing two billion dollars and the business approaching self-sustaining profitability. Terminal valuation multiples fully compress to reflect a mature industrial technology leader, establishing sustainable market equilibrium. |
The enterprise investment case presents a fundamental dichotomy between technological progress and per-share economic reality. Consolidation of domestic foundry infrastructure and proprietary trapped-ion control bolsters federal defense contracting and operational hardware iteration. However, headline top-line acceleration is heavily distorted by acquired low-margin contract fabrication and mark-to-market warrant swings that disguise persistent negative free cash flow. In an elevated discount-rate environment with benchmark yields near five percent, the market's extreme price-to-sales multiple faces unavoidable decompression toward capital-intensive hardware comparables. Underlying technology progress survives, but multiple compression and ongoing capital structure dilution will severely limit per-share equity realization.
Key insights
- Acquired merchant foundry revenue permanently lowers blended corporate gross margins, forcing institutional valuation frameworks to transition from pure software to industrial hardware multiples.
- Massive derivative warrant liabilities and stock-based compensation steadily expand share count, ensuring that operational revenue expansion delivers disproportionately diluted equity gains per share.
- Sovereign defense appropriations provide an essential non-dilutive revenue backstop, yet commercial enterprise software adoption remains insufficient to bridge annual operational cash deficits.
The company is growing rapidly on paper by purchasing semiconductor manufacturing factories and winning government defense research contracts. However, this growth comes at a steep price: the newly acquired businesses produce much lower profit margins and require massive cash spending. Because interest rates are elevated, investors are no longer willing to pay speculative prices for distant promises, meaning the stock faces significant headwinds despite technological achievements.
Key insights
- Buying industrial manufacturing plants rapidly increases reported revenue but permanently drags down corporate profit margins.
- Continuous issuance of new shares to fund massive cash spending dilutes existing investors and per-share value.
- Government defense contracts provide reliable financial support, but commercial enterprise customers are adopting quantum tools slowly.
Deep Dive
Prevailing market consensus treats the company as an undisputed pure-play champion of quantum computing, extrapolating rapid headline revenue growth and sovereign defense awards into an unassailable commercial monopoly. The crowd heavily anchors on visionary algorithmic milestones and cash reserves, assuming that acquired semiconductor foundry assets validate vertical integration while overlooking that reported top-line expansion relies on low-margin contract fabrication and non-cash accounting adjustments.